February 24, 2025
A Delaware federal judge Monday threw out Natera's $96 million patent infringement verdict against CareDx after determining that the asserted claims in its patents related to DNA tests for organ transplant recipients are invalid.
January 03, 2025
A Delaware federal judge denied Natera's bid for a new trial in a case where a jury awarded the DNA test company $96 million in damages after finding rival CareDx stole from one of its patents but didn't infringe a second patent, saying Friday that sufficient evidence backed the verdict.
January 29, 2024
A Delaware jury has moved to award Natera over $96 million in damages after finding that rival CareDx infringed one of its patents through the sale of its DNA tests for organ transplant recipients.
December 11, 2023
A Delaware federal judge gave CareDx a partial win Monday in patent litigation filed by Natera, finding that one of three patents-at-issue was invalid as covering patent-ineligible subject matter.